Summer Special! Get NewsNow Essentials at just £2.99 a month (25% OFF!). Faster, slicker, customisable & ad free!Summer Special! Get NewsNow Essentials at just £2.99 a month (25% OFF!). Subscribe and saveSummer Special! Upgrade here at £2.99/m (25% OFF!)

Home
Hot Topics
Australia
World
Sport
Business
Entertainment
Science
Technology
Lifestyle

BioNTech
Biotech
Moderna
Biogen
Topics

Advertisement

BioNTech

Share

Top Latest Popular

Stat Plus: BioNTech names Guido Oelkers its new CEO STAT 5d

STAT 5d

EU regulatory roundup: AbbVie, Pfizer & BioNTech and Incyte net approvals Pharmaceutical Technology 16:48 Thu, 30 Jul

Pharmaceutical Technology 16:48 Thu, 30 Jul

BioNTech's next act has nothing to do with covid. Here's the $500 billion market some investors are ignoring The Motley Fool 23:50 Thu, 23 Jul

The Motley Fool 23:50 Thu, 23 Jul

Advertisement

Poland appeals Brussels ruling in Pfizer vaccine dispute TheNews.pl 4d

TheNews.pl 4d

Tzu Chi allegedly defrauded of NT$1 billion in vaccine case Taiwan News 1d

Taiwan News 1d

BioNTech Q2 net loss widens, lowers FY26 revenue outlook; stock falls in pre-market RTT News 3d

RTT News 3d

Advertisement

Advertisement

Latest

Thursday

Tzu Chi allegedly defrauded of NT$1 billion in vaccine case Taiwan News 13:05 Thu, 06 Aug

Downgrade: Here's How Analysts See BioNTech SE (NASDAQ:BNTX) Performing In The Near Term Simply Wall St 12:40 Thu, 06 Aug

Tuesday

Deeper Losses And New CEO Could Be A Game Changer For BioNTech’s (BNTX) R&D Strategy Simply Wall St 16:21 Tue, 04 Aug

BioNTech Q2 Net Loss Widens, Lowers FY26 Revenue Outlook; Stock Falls In Pre-Market RTT News 13:47 Tue, 04 Aug

Monday

Sobi CEO Guido Oelkers Will Lead BioNTech’s Transition To Oncology Player Scrip Pharma Intelligence 22:34 Mon, 03 Aug

Poland appeals Brussels ruling in Pfizer vaccine dispute TheNews.pl 13:13 Mon, 03 Aug

BioNTech appoints Guido Oelkers as new Chief Executive Officer European Pharmaceutical Review 12:55 Mon, 03 Aug

STAT Plus: BioNTech names Guido Oelkers its new CEO STAT 12:29 Mon, 03 Aug

In the last month

EU regulatory roundup: AbbVie, Pfizer & BioNTech and Incyte net approvals Pharmaceutical Technology 16:48 Thu, 30 Jul

BioNTech (BNTX) Could Be 81% Undervalued After New Vaccine Patent Lawsuits Simply Wall St 04:16 Thu, 30 Jul

Advertisement

Advertisement

Advertisement

About our BioNTech news

Latest news on BioNTech, a German biotechnology company that makes active immunotherapies for patient-specific approaches to the treatment of diseases.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Biotech Biotech
Back to Business Biotech
- GM Food GM Food
- AbbVie AbbVie
- Amgen Amgen
- Biogen Biogen
- BioNTech BioNTech
- Celltrion Celltrion
- Genentech Genentech
- Gilead Sciences
- Illumina Illumina
- Moderna Moderna